Quanying Zhang
Overview
Explore the profile of Quanying Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li X, Chang H, Zhang Q, Yang J, Liu R, Song Y
BMC Nurs
. 2025 Mar;
24(1):263.
PMID: 40065308
No abstract available.
2.
Liu Z, Song S, Zhang Q, Wang D
J Orthop
. 2024 Dec;
64:64-67.
PMID: 39691640
As human lifespan increases and the proportion of obese people increases, the prevalence of knee osteoarthritis continues to increase. Its main clinical manifestations include joint pain, snapping, and decreased joint...
3.
Xing G, Zhang Q, Tian L, Liu G, Wu N, Xie T
Appl Radiat Isot
. 2024 Sep;
213:111499.
PMID: 39243553
Carbon/Oxygen logging is an effective method to perform oil layer recognition and oil saturation calculation, which plays an important role in the evaluation of remaining oil after casing. At present,...
4.
Song S, Liu Z, Zhang Q
Int J Orthop Trauma Nurs
. 2024 Aug;
54:101124.
PMID: 39096627
Background: With the advent of an ageing era, the number of elderly patients undergoing knee joint replacement is increasing. Postoperative long-term standardized functional exercise is a focal point and difficulty...
5.
Qu Y, Zhou W, Wang M, Zhang Q, Su M, Pan J
Eur J Pharm Sci
. 2024 Mar;
196:106747.
PMID: 38467333
H018 is an orally administered, selective, small-molecule inhibitor of Janus kinase 1 (JAK1) made for the treatment of rheumatoid arthritis. A population pharmacokinetic/pharmacodynamic analysis was conducted to characterize the pharmacokinetic...
6.
Hu W, Wang Y, Zhang Q, Luo Q, Huang N, Chen R, et al.
Cell Signal
. 2023 Aug;
110:110833.
PMID: 37543098
MicroRNAs (miRs) are 18-25 nucleotides non-coding RNAs, which contribute to tumorigenesis. Previous studies have demonstrated that miR-199a-3p is dysregulated in human nasopharyngeal carcinoma (NPC), but its role in NPC progression...
7.
Hua W, Zhou W, Su M, Zhang Q, Zong S, Wang M
Clin Pharmacol Drug Dev
. 2023 May;
12(9):881-887.
PMID: 37140399
Ibuprofen, a nonsteroidal anti-inflammatory drug, is considered a safe and effective analgesic for treating different types of pain and joint disorders. Dexibuprofen, S-(+)-ibuprofen, is the single pharmacologically active enantiomer of...
8.
Zhou W, Wang M, Yu Y, Wang J, Wu Y, Yang G, et al.
Expert Opin Biol Ther
. 2023 Feb;
23(8):717-725.
PMID: 36843059
Background: HLX02, the first China-manufactured trastuzumab biosimilar, is approved in Europe (EU) and China. This study evaluated bioequivalence between HLX02 and US-approved trastuzumab (US-trastuzumab). Method: In this double-blind, parallel-group, Phase...
9.
Wang M, Zhu Y, Huang M, Wang H, Zhou W, Lu D, et al.
Clin Pharmacol Drug Dev
. 2022 Jul;
11(10):1233-1240.
PMID: 35900031
Nilotinib, a second-generation tyrosine kinase inhibitor (TKI), has been approved in the United States and Europe as a treatment for patients with newly diagnosed chronic myeloid leukemia (CML)-chronic phase (CP)...
10.
Wang P, Deng J, Zhang Q, Feng H, Zhang Y, Lu Y, et al.
Front Pharmacol
. 2022 Feb;
13:817119.
PMID: 35222031
Combination therapy has become an attractive option in pulmonary arterial hypertension (PAH) treatment. The aim of this study was to investigate whether additional use of prostacyclin analogs could exert any...